"Tissue" transglutaminase expression in HIV-infected cells: an enzyme with an antiviral effect?
- PMID: 11762979
"Tissue" transglutaminase expression in HIV-infected cells: an enzyme with an antiviral effect?
Abstract
The cytopathic effect of HIV has been shown to be associated with the induction of apoptosis and the inhibition of proliferation of T cells. However, the cellular and molecular mechanisms at the basis of the dramatic immune cell loss caused by HIV in patients suffering from acquired immunodeficient syndrome (AIDS), are not yet fully established. We demonstrated that "tissue" transglutaminase (tTG) gene expression is induced in the immune system of seropositive individuals (peripheral blood mononuclear cells and lymph nodes). tTG is a multifunctional protein involved in a variety of fundamentally important cellular functions, in addition to cell death by apoptosis. The presence of high tTG levels in immune-competent cells of HIV+ persons might exert an important role in HIV-infection by influencing viral production. We propose that, in addition to its multiple functions, tTG might interfere with HIV replication by altering the viral mRNA trafficking between the nucleus and the cytoplasm. This effect might be due to its specific interaction with eIF5A, a cellular partner of HIV Rev protein, which is essential for HIV replication in immune-competent cells. Given the presence of high tTG levels in HIV+ individuals, it would be of interest to pursue the potential role of this multifunctional protein in the development of strategies aimed at the pharmacologic regulation of HIV production.
Similar articles
-
Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.Eur J Immunol. 2003 Jan;33(1):252-63. doi: 10.1002/immu.200390028. Eur J Immunol. 2003. PMID: 12594854
-
"Tissue" transglutaminase and apoptosis.Adv Biochem Eng Biotechnol. 1998;62:129-36. Adv Biochem Eng Biotechnol. 1998. PMID: 9755643 Review.
-
Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?AIDS Rev. 2006 Jan-Mar;8(1):3-8. AIDS Rev. 2006. PMID: 16736946 Review.
-
Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.Exp Cell Res. 2006 Oct 1;312(16):2973-82. doi: 10.1016/j.yexcr.2006.05.019. Epub 2006 Jun 7. Exp Cell Res. 2006. PMID: 16914140
-
Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals.Infection. 2008 Mar;36(2):120-9. doi: 10.1007/s15010-008-7368-9. Epub 2008 Mar 31. Infection. 2008. PMID: 18379725
Cited by
-
Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis.Int J Mol Sci. 2021 Feb 14;22(4):1897. doi: 10.3390/ijms22041897. Int J Mol Sci. 2021. PMID: 33672962 Free PMC article. Review.
-
Transglutaminase 2 Up-Regulation Is Associated with Inflammatory Response in PBMC from Healthy Subjects with Hypovitaminosis D.Med Sci (Basel). 2018 Nov 16;6(4):103. doi: 10.3390/medsci6040103. Med Sci (Basel). 2018. PMID: 30453584 Free PMC article.
-
CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models.Sci Rep. 2020 Mar 24;10(1):5350. doi: 10.1038/s41598-020-62375-3. Sci Rep. 2020. PMID: 32210344 Free PMC article.
-
Lack of transglutaminase 2 diminished T-cell responses in mice.Immunology. 2014 Jul;142(3):506-16. doi: 10.1111/imm.12282. Immunology. 2014. PMID: 24628083 Free PMC article.
-
Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death.Cell Death Dis. 2016 Jun 2;7(6):e2244. doi: 10.1038/cddis.2016.150. Cell Death Dis. 2016. PMID: 27253408 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
